Healthcare Companies' Annual Reports & Investor Relations Material

1067 Companies

TBPH

Theravance Biopharma

Theravance Biopharma, a prominent biopharmaceutical firm, has been making waves with its groundbreaking respiratory medicines, which are developed and distributed across the United States and Europ...

Theravance Biopharma Annual Report 2023

Healthcare Biotechnology NASDAQ 201-500

STE

STERIS

Dublin-based STERIS plc is a worldwide provider of infection prevention products and services across four major business segments. Its Healthcare segment includes automated endoscope reprocessing s...

STERIS Annual Report 2023

Healthcare Medical Appliances & Equipment NYSE 10,000+

BCRX

BioCryst Pharmaceuticals

BioCryst Pharmaceuticals, Inc., a leading biotechnology company headquartered in Durham, North Carolina, has made significant strides in the field of small-molecule medicines. With a focus on disco...

BioCryst Pharmaceuticals Annual Report 2023

Healthcare Biotechnology NASDAQ 201-500

DNL

Diurnal Group plc

Diurnal Group plc is a specialty pharmaceutical company that develops hormone therapeutics for the treatment of chronic endocrine conditions. Based in Cardiff, UK, the company's products aim to add...

Diurnal Group plc Annual Report 2020

Healthcare Drug Manufacturers - Other LSE 11-50

MOTS

Motus GI

Motus GI Holdings, Inc., a US-based medical technology company, has reportedly developed a groundbreaking medical device that promises to revolutionize the gastrointestinal (GI) tract cleansing pro...

Motus GI Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

APYX

Apyx Medical

Apyx Medical Corporation, a global leader in energy technology, is revolutionizing the medical device industry with its cutting-edge products in the cosmetic and surgical markets. The Florida-based...

Apyx Medical Annual Report 2020

Healthcare Medical Appliances & Equipment NASDAQ 201-500

CBPO

China Biologic Products, Inc.

China Biologic Products, Inc. (NASDAQ: CBPO) is a prominent Chinese biopharmaceutical company that specializes in plasma-based therapies. The company's products are widely used for emergency medica...

China Biologic Products, Inc. Annual Report 2018

Healthcare Biotechnology NASDAQ 1001-5000

EYPT

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals Aiming to Enhance Lives of Patients with Serious Eye Disorders EyePoint Pharmaceuticals, Inc. is a United States-based pharmaceutical company dedicated to developing and c...

EyePoint Pharmaceuticals Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

PDEX

Pro-Dex

California-based Pro-Dex, Inc. is a global leader in the design, development, and distribution of powered surgical instruments for medical device original equipment manufacturers. The company speci...

Pro-Dex Annual Report 2023

Healthcare Medical Instruments & Supplies NASDAQ 51-200

GERN

Geron

Late-stage clinical biopharmaceutical company Geron Corporation is laser-focused on developing and commercializing therapeutic solutions for myeloid hematologic malignancies. Its promising telomera...

Geron Annual Report 2023

Healthcare Drug Manufacturers - Other NASDAQ 51-200

TYME

Tyme

Tyme Technologies, Inc. is a biotech firm that is focused on developing cancer metabolism-based treatments that have low toxicity and can be effective for various kinds of tumors. The firm's approa...

Tyme Annual Report 2021

Healthcare Biotechnology NASDAQ 11-50

MCRB

Seres Therapeutics

Seres Therapeutics, a company focused on microbiome therapeutics, is working to develop a unique class of biological drugs for the modulation of the colonic microbiome. The company's lead candidate...

Seres Therapeutics Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

ILF

Ingenia Communities Group

Ingenia Communities Group, an independent real estate investment trust, has been making strategic investments in Australia, Canada, New Zealand, and the United States. The company specializes in ow...

Ingenia Communities Group Annual Report 2023

Healthcare Medical Laboratories & Research ASX 201-500

APVO

Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc., a clinical-stage biotechnology company, is working on developing immunotherapeutic candidates in the United States for various types of cancer. Its lead clinical candidate...

Aptevo Therapeutics Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

IGMS

IGM Biosciences

IGM Biosciences, a clinical-stage biotech firm, is on a mission to produce Immunoglobulin M (IgM) antibodies that may help fight cancer, infectious diseases, as well as autoimmune and inflammatory ...

IGM Biosciences Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200